New COVID Origins Data Point to Raccoon Dogs in China Market

The Huanan Seafood Wholesale Market, sits closed in Wuhan in central China's Hubei province on Jan. 21, 2020. (AP)
The Huanan Seafood Wholesale Market, sits closed in Wuhan in central China's Hubei province on Jan. 21, 2020. (AP)
TT

New COVID Origins Data Point to Raccoon Dogs in China Market

The Huanan Seafood Wholesale Market, sits closed in Wuhan in central China's Hubei province on Jan. 21, 2020. (AP)
The Huanan Seafood Wholesale Market, sits closed in Wuhan in central China's Hubei province on Jan. 21, 2020. (AP)

Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, suggesting the pandemic may have originated from animals, not a lab, international experts say.

Other experts have not yet verified their analysis, which has yet to appear in a peer-reviewed journal. How the coronavirus began sickening people remains uncertain. The sequences will have to be matched to the genetic record of how the virus evolved to see which came first.

"These data do not provide a definitive answer to how the pandemic began, but every piece of data is important to moving us closer to that answer," World Health Organization Director-General Tedros Adhanom Ghebreyesus said Friday.

He criticized China for not sharing the genetic information earlier, telling a press briefing that "this data could have and should have been shared three years ago."

The samples were collected from surfaces at the Huanan seafood market in early 2020 in Wuhan, where the first human cases of COVID-19 were found in late 2019.

Tedros said the genetic sequences were recently uploaded to the world's biggest public virus database by scientists at the Chinese Center for Disease Control and Prevention.

They were then removed, but not before a French biologist spotted the information by chance and shared it with a group of scientists based outside China that's looking into the origins of the coronavirus.

The data show that some of the COVID-positive samples collected from a stall known to be involved in the wildlife trade also contained raccoon dog genes, indicating the animals may have been infected by the virus, according to the scientists. Their analysis was first reported in The Atlantic.

"There’s a good chance that the animals that deposited that DNA also deposited the virus," said Stephen Goldstein, a virologist at the University of Utah who was involved in analyzing the data. "If you were to go and do environmental sampling in the aftermath of a zoonotic spillover event … this is basically exactly what you would expect to find."

Ray Yip, an epidemiologist and founding member of the US Centers for Disease Control office in China, said the findings are significant, even though they aren't definitive.

"The market environmental sampling data published by China CDC is by far the strongest evidence to support animal origins," Yip told the AP in an email. He was not connected to the new analysis.

WHO's COVID-19 technical lead, Maria Van Kerkhove, cautioned that the analysis did not find the virus within any animal, nor did it find any hard evidence that any animals infected humans.

"What this does provide is clues to help us understand what may have happened," she said. The international group also told WHO they found DNA from other animals as well as raccoon dogs in the samples from the seafood market, she added.

"There's molecular evidence that animals were sold at Huanan market and that is new information," Van Kerkhove said.

Efforts to determine the origins of the COVID-19 pandemic have been complicated by factors including the massive surge of human infections in the pandemic's first two years and an increasingly bitter political dispute.

It took virus experts more than a dozen years to pinpoint the animal origin of SARS, a related virus.

Goldstein and his colleagues say their analysis is the first solid indication that there may have been wildlife infected with the coronavirus at the market. But it is also possible that humans brought the virus to the market and infected the raccoon dogs, or that infected humans simply happened to leave traces of the virus near the animals.

After scientists in the group contacted the China CDC, they say, the sequences were removed from the global virus database. Researchers are puzzled as to why data on the samples collected over three years ago wasn’t made public sooner. Tedros has pleaded with China to share more of its COVID-19 research data.

Gao Fu, the former head of the Chinese CDC and lead author of the Chinese paper, didn’t immediately respond to an Associated Press email requesting comment. But he told Science magazine the sequences are "nothing new. It had been known there was illegal animal dealing and this is why the market was immediately shut down."

Goldstein said his group presented its findings this week to an advisory panel the WHO has tasked with investigating COVID-19’s origins.

Mark Woolhouse, an infectious diseases expert at the University of Edinburgh, said it will be crucial to see how the raccoon dogs' genetic sequences match up to what's known about the historic evolution of the COVID-19 virus. If the dogs are shown to have COVID and those viruses prove to have earlier origins than the ones that infected people, "that’s probably as good evidence as we can expect to get that this was a spillover event in the market."

After a weeks-long visit to China to study the pandemic's origins, WHO released a report in 2021 concluding that COVID-19 most probably jumped into humans from animals, dismissing the possibility of a lab origin as "extremely unlikely."

But the UN health agency backtracked the following year, saying "key pieces of data" were still missing. And Tedros has said all hypotheses remain on the table.

The China CDC scientists who previously analyzed the Huanan market samples published a paper as a preprint in February suggesting that humans brought the virus to the market, not animals, implying that the virus originated elsewhere. Their paper didn't mention that animal genes were found in the samples that tested positive.

Wuhan, the Chinese city where COVID-19 was first detected, is home to several labs involved in collecting and studying coronaviruses, fueling theories that the virus may have leaked from one.

In February, the Wall Street Journal reported that the US Department of Energy had assessed "with low confidence" that the virus had leaked from a lab. But others in the US intelligence community disagree, believing it more likely it first came from animals. Experts say the true origin of the pandemic may not be known for many years — if ever.



Trump's Triumphal Arch Gets Official Name

White House Press Secretary Karoline Leavitt shows off an artist's rendering of President Donald Trump's planned Triumphal Arch. Brendan SMIALOWSKI / AFP
White House Press Secretary Karoline Leavitt shows off an artist's rendering of President Donald Trump's planned Triumphal Arch. Brendan SMIALOWSKI / AFP
TT

Trump's Triumphal Arch Gets Official Name

White House Press Secretary Karoline Leavitt shows off an artist's rendering of President Donald Trump's planned Triumphal Arch. Brendan SMIALOWSKI / AFP
White House Press Secretary Karoline Leavitt shows off an artist's rendering of President Donald Trump's planned Triumphal Arch. Brendan SMIALOWSKI / AFP

It's been dubbed the "Arc de Trump." But now President Donald Trump's latest building project has an official name -- the "United States Triumphal Arch."

White House Press Secretary Karoline Leavitt revealed the formal title on Wednesday, saying the giant structure was being built to mark the 250th anniversary of US independence, AFP reported.

"In honor of this historic occasion, President Trump and the Department of Interior will submit plans for the United States Triumphal Arch," Leavitt told reporters.

Showing off a picture that she initially held upside down, Leavitt said the "monumental" arch would stand 250 feet (76.2 meters) tall "in honor of 250 years."

Its colossal height, including a huge golden Lady Liberty statue on top, means it will dwarf perhaps its most famous predecessor, the Arc de Triomphe in Paris, which stands at 164 feet.

In fact it is set to be the largest structure of its kind in the world, pipping Mexico City's Monument to the Revolution and knocking Pyongyang's Arch of Triumph to third place.

Plans for the arch were first revealed in October when AFP journalists spotted a model on Trump's desk in the Oval Office, after which it was quickly dubbed the "Arc de Trump" by US media.

Trump revealed the first full renderings for the structure last Friday.

The arch is one of several architectural projects -- including the construction of a gigantic White House ballroom and renovations to the Kennedy Center for the Performing Arts -- that Trump has undertaken to leave a mark on Washington in his second term.

Critics say the gold-accented arch, which will tower over the 99-foot-tall Lincoln Memorial, is a monument to the 79-year-old Trump's vanity.

The arch will partly be funded by US taxpayers, getting $2 million in special funds from the US National Endowment for the Humanities, with up to $13 million in funds to match any donations, ABC News reported.

But Leavitt said it was aimed at celebrating US national pride.

"Long after everyone in this room is gone, our children and grandchildren will remain inspired by this national monument," she told reporters.


Much-hyped Alzheimer's Drugs Do Not Help Patients, Review Finds

New research has cast doubt on Alzheimer's drugs once hailed as a gamechanger. ALAIN JOCARD / AFP/File
New research has cast doubt on Alzheimer's drugs once hailed as a gamechanger. ALAIN JOCARD / AFP/File
TT

Much-hyped Alzheimer's Drugs Do Not Help Patients, Review Finds

New research has cast doubt on Alzheimer's drugs once hailed as a gamechanger. ALAIN JOCARD / AFP/File
New research has cast doubt on Alzheimer's drugs once hailed as a gamechanger. ALAIN JOCARD / AFP/File

Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major review found Thursday, however some experts criticized the research.

The review by the Cochrane organization -- which is considered the gold standard for analyzing existing evidence -- looked at drugs that target a plaque called amyloids which builds up in the brains of Alzheimer's patients.

Researchers have long sought a way to eliminate this plaque, believing it could be the cause of the most common form of dementia which affects millions of elderly people every year, said AFP.

After decades of costly yet unsuccessful research, two anti-amyloid drugs called lecanemab and donanemab were initially hailed as gamechangers that finally offered a way to slow the progress of the debilitating disease.

Both drugs were approved by the United States and European Union over the last few years.

However concerns about their effectiveness, cost and side effects including an increased risk of brain swelling and bleeding have since prompted caution. State-run health services in the UK and France have refused to cover the drugs.

The new Cochrane review combined data from 17 clinical trials that included a total of more than 20,000 people with mild cognitive impairment or early dementia.

The trials, which took place over roughly 18 months, studied seven different anti-amyloid drugs.

Only one of the trials examined donanemab -- sold under the name Kisunla by US pharma giant Eli Lilly -- while one studied lecanemab, sold as Leqembi by Biogen and Eisai.

While early trials suggested these drugs made a statistically significant difference, this did not translate into "something clinically meaningful for patients," lead study author Francesco Nonino of Italy's IRCCS institute told a press conference.

Brain scans showed that the drugs successfully removed amyloids, the researchers emphasized.

This means "the idea that removing amyloids will benefit patients was refuted by our results," said study co-author Edo Richard of Radboud University Medical Center in the Netherlands.

- 'Not delivering on promise' -

Richard, who has previously expressed skepticism about anti-amyloid drugs, said he hopes efforts targeting other mechanisms that potentially cause Alzheimer's lead to more effective drugs in the future.

British biologist John Hardy, who first developed the amyloid hypothesis in the 1990s, criticized the review for lumping together data about lecanemab and donanemab along with drugs that are known to be ineffective, therefore dragging down the overall average.

"This is a silly paper which should not have been published," Hardy told AFP, disclosing that he has consulted for Eli Lilly, Biogen and Eisai.

In response to such questions, Richard said that while the drugs included in the study may work in different ways, they all have the same target: amyloid beta proteins.

Australian neuroscientist Bryce Vissel, who was not involved in the research, said it "does not prove amyloid has no role in Alzheimer's, and it does not rule out future amyloid-directed therapies that may yet help patients".

"But it does show that the current generation of anti-amyloid drugs is not delivering the promise that has surrounded it."


Indonesia Police Arrest Six for Komodo Dragon Smuggling

A komodo dragon is displayed by nature and conservation agency officials and police officers after being seized from suspects attempting to smuggle it into Thailand, during a press conference at the regional police headquarters in Surabaya on April 15, 2026. (Photo by JUNI KRISWANTO / AFP)
A komodo dragon is displayed by nature and conservation agency officials and police officers after being seized from suspects attempting to smuggle it into Thailand, during a press conference at the regional police headquarters in Surabaya on April 15, 2026. (Photo by JUNI KRISWANTO / AFP)
TT

Indonesia Police Arrest Six for Komodo Dragon Smuggling

A komodo dragon is displayed by nature and conservation agency officials and police officers after being seized from suspects attempting to smuggle it into Thailand, during a press conference at the regional police headquarters in Surabaya on April 15, 2026. (Photo by JUNI KRISWANTO / AFP)
A komodo dragon is displayed by nature and conservation agency officials and police officers after being seized from suspects attempting to smuggle it into Thailand, during a press conference at the regional police headquarters in Surabaya on April 15, 2026. (Photo by JUNI KRISWANTO / AFP)

Indonesian authorities said Wednesday they have arrested six people allegedly involved in smuggling endangered Komodo dragons native to the archipelago and destined for Thailand.

Two suspects were arrested in February in the port city of Surabaya on the east coast of Java island as they got off a ship with three live Komodo dragons -- the world's largest living lizard.

Further investigation led to four more arrests in the weeks that followed, AFP reported.

Police said the animals had been obtained from "suppliers or hunters" in Indonesia's East Nusa Tenggara province, where they are native to a handful of small islands.

The suspects are accused of buying the dragons for 5.5 million rupiah (about $320) apiece and selling them for six times the price, apparently to be shipped to clients in Thailand.

According to East Java police, the suspects have smuggled and traded at least 20 Komodo dragons since January last year, and pocketed some $33,000.

They face up to five years in prison and a fine.

The International Union for Conservation of Nature lists the Komodo dragon as endangered, with a global population of about 3,400, including juveniles.

The fearsome reptiles, which can grow to three meters (10 feet) in length and weigh up to 90 kilograms (200 pounds), are threatened by human activity and by climate change destroying their habitat.

Poachers collect them to be sold as pets or display animals.

Komodo dragons in the wild are found only in Indonesia's World Heritage-listed Komodo National Park and on neighboring Flores island.

Police said Wednesday they had also arrested two suspects for smuggling 140 kilograms of pangolin scales from the northwestern province of Riau to Surabaya.

Pangolins are among the world's most endangered species, and their scales are prized in countries like China and Vietnam, where they are used in traditional remedies even though they provide no scientifically proven medicinal benefit.